HomeINBX • NASDAQ
Inhibrx Biosciences Inc
add
$12.54
4.71%
After Hours:(0.00%)0.00
$12.54
Closed: May 22, 4:02:04 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 41.65M | -40.19% |
Net income | -43.31M | 44.97% |
Net profit margin | — | — |
Earnings per share | -2.80 | — |
EBITDA | -42.23M | 42.52% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 216.52M | — |
Total assets | 242.64M | 759.75% |
Total liabilities | 148.20M | 280.07% |
Total equity | 94.44M | — |
Shares outstanding | 14.48M | — |
Price to book | 2.02 | — |
Return on assets | -50.66% | — |
Return on capital | -62.61% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -43.31M | 44.97% |
Cash from operations | -35.90M | 43.07% |
Cash from investing | -21.00K | 98.12% |
Cash from financing | 99.84M | 157.80% |
Net change in cash | 63.92M | 351.26% |
Free cash flow | -21.39M | 63.76% |
Previous close
$13.16
Day range
$12.50 - $13.07
Year range
$10.80 - $18.95
Market cap
181.53M USD
Avg Volume
104.74K
P/E ratio
0.11
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2024
Headquarters
Website
Employees
159
